Subscribe to Newsletter

Detection and quantitation of benzodiazepines in less than 3 min using PESI-MS

Benzodiazepines (BZDs), which were the most prescribed medications globally in the 80s, remain frequently used as recreational drugs and are implicated in drug-facilitated sexual assaults or driving under influence of drugs cases. They are used for their anxiolytic, sedative, muscle relaxant and anticonvulsant properties. For that reasons, quantitative screening of BZDs is a routine work for emergency samples in a clinical toxicology context. Laboratories typically rely on immunochromatography (lateral flow test) or immunohistochemistry methods which quickly generate a result but often suffer from two major drawbacks:

  • numerous false negative results
  • only qualitative information
Read the full article now

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register